Quality of life and treatment satisfaction in adults with Type 1 diabetes: A comparison between continuous subcutaneous insulin infusion and multiple daily injections

Diabetic Medicine

Volumn 25, Issue 2, 2008, Pages 213-220

  Nicolucci, A ^a,j   Maione, A ^a   Franciosi, M ^a   Amoretti, R ^b   Busetto, E ^c   Capani, F ^d,k   Bruttomesso, D ^e   Di Bartolo, P ^f   Girelli, A ^g   Leonetti, F ^h   Morviducci, L ⁱ   Ponzi, P ^c   Vitacolonna, E ^d,k  

^a Santa Maria Imbaro   (Italy)

^b SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^c Fondazione Medtronic Italia   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f AUSL Ravenna   (Italy)

^g Diabetes Unit   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^j Online University 'Leonardo Da Vinci' ^*  (Italy)

^k Online University 'Leonardo Da Vinci'   (Italy)

more..

Author keywords

Continuous subcutaneous insulin infusion; Multiple daily injections; Quality of life; Questionnaires; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; ISOPHANE INSULIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC DIET; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DOSAGE SCHEDULE COMPARISON; EDUCATIONAL STATUS; FEAR; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIPLE DRUG DOSE; MULTIVARIATE ANALYSIS; OCCUPATION; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SHORT FORM 36; SOCIOECONOMICS;

ADULT; DIABETES MELLITUS, TYPE 1; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE;

EID: 39749191362     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02346.x     Document Type: Article

References (30)

1. Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 2004 8 : 1 171.
2. Centers for Disease Control Prevention (CDC). Self-rated fair or poor health among adults with diabetes - United States, 1996-2005. MMWR Morb Mortal Wkly Rep 2006 55 : 1224 1227.
3. Huang GH, Palta M, Allen C, LeCaire T, D'Alessio D Wisconsin Diabetes Registry. Self-rated health among young people with Type 1 diabetes in relation to risk factors in a longitudinal study. Am J Epidemiol 2004 159 : 364 372.
4. Koopmanschap M CODE-2 Advisory Board. Coping with Type II diabetes: the patient's perspective. Diabetologia. 2002 45 : S18 S22.
5. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997 20 : 562 567.
6. Barnard KD, Lloyd CE, Skinner TC. Systematic literature review: quality of life associated with insulin pump use in Type1 diabetes. Diabet Med 2007 24 : 607 617.
7. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with Type 1 diabetes. Diabetes Care 1999 22 : 1779 1784.
8. Tsui E, Barnie A, Ross S, Parkes R, Zinman B. Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care 2001 24 : 1722 1727.
9. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ. Dutch Insulin Pump Study Group: A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in Type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 2002 25 : 2074 2080.
10. Linkeschova R, Raoul M, Bott U, Berger M, Spraul M. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002 19 : 746 751.
11. Bruttomesso D, Pianta A, Crazzolara D, Scaldaferri E, Lora L, Guarneri G et al. Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. Diabet Med 2002 19 : 628 634.
12. Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med 2005 23 : 141 147.
13. McKeage K, Goa KL. Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of Type 1 and 2 diabetes mellitus. Drugs 2001 61 : 1599 1624.
14. Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in Type 2 diabetes. Diabetes Care 2005 28 : 950 955.
15. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D, Di Nardo B et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in Type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care 2001 24 : 1870 1877.
16. Bott U, Muhlhauser I, Overmann H, Berger M. Validation of a diabetes-specific quality-of-life scale for patients with Type 1 diabetes. Diabetes Care 1998 21 : 757 769.
17. Bott U, Ebrahim S. Further development of a quality-of-life measure for IDDM patients. Diabetologia 1998 41 : A74 (Abstract).
18. Ware JE Jr., Gandeck BL, Keller SD, the IQOLA Project Group. Evaluating instruments used cross-nationally: methods from the IQOLA Project. in quality of life and pharmacoecoeconomics. In : Spilker B, ed. Clinical Trials, 2nd edn. Philadelphia : Lippincott-Raven Publishers, 1996 : 681 692.
19. Bradley C. Diabetes Treatment Satisfaction Questionnaire (DTSQ). In : Bradley C, ed. Handbook of Psychology and Diabetes. Chur, Switzerland : Harwood Academic Publishers, 1994 : 111 132.
20. Nicolucci A, Giorgino R, Cucinotta D, Zoppini G, Muggeo M, Squatrito S et al. Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). Diabetes Nutr Metab 2004 17 : 235 243.
21. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 30 : 473 483.
22. McHorney CA, Ware JE Jr., Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994 32 : 40 66.
23. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998 51 : 1025 1036.
24. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials 1990 11 : 116 128.
25. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N, for the European Regulatory Issues on Quality of Life Assessment Group. Patient-reported outcomes: the example of health-related quality of life - a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J 2002 36 : 209 238.
26. SAS® Language, Version 9.1. Cary : SAS Institute Inc., 2002-2003.
27. Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev 2002 18 (Suppl 3 S64 S69.
28. Hoogma RP, Spijker AJ, van Doorn-Scheele M, van Doorn TT, Michels RP, van Doorn RG et al. Quality of life and metabolic control in patients with diabetes mellitus Type 1 treated by continuous subcutaneous insulin infusion or multiple daily insulin injections. Neth J Med 2004 62 : 383 387.
29. Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ. Impact of hypoglycaemia on quality of life and productivity in Type 1 and Type 2 diabetes. Curr Med Res Opin 2005 21 : 1477 1483.
30. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in Type 1 diabetes. Diabetes Care 2002 25 : 593 598.